Main > HEPATOLOGY > Hepatitis B Virus > Infection. Treatment > Entecavir > Co.: USA. B (Brand Tablets/Patents)

---

Co.: USA. B (Brand Tablets/Patents)'s subsections
Approval Date: 03.29.2005
Chronic HBV Infection Treatment
Company
Guanosine Nucleoside Analogue
Patent>Deliv.>Tablet Formulation
Patent>DisClosure
Patent>Synthesis
Patent>Total USA No.: 3
Patent>UpDtate: 01.02.07
Patent>US Expiration: 09.20.2011
Strengths: 0.5; 1.0 mg
Structural Name
TradeMark
UpDate: 03.24.08. (PR)
Web-Site

Co.: USA. B (Brand Tablets/Patents)'s products
This section has no products